Duquesne Family Office’s iShares Biotechnology ETF IBB Stock Holding History

Duquesne Family Office’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-791,200	Closed	-$88.5M	–	68
2019 Q1	$88.5M	Buy	791,200 +440,900	+126%	+$48.4M	2.56%	11
2018 Q4	$33.8M	Sell	350,300 -682,600	-66%	-$72.5M	1.96%	15
2018 Q3	$126M	Buy	1,032,900 +849,000	+462%	+$100M	5.99%	5
2018 Q2	$20.3M	Buy	+183,900	New	+$19.7M	0.98%	23
2017 Q4	–	Sell	-332,100	Closed	-$36.9M	–	41
2017 Q3	$36.9M	Buy	332,100 +84,900	+34%	+$9.07M	1.68%	17
2017 Q2	$25.6M	Buy	+247,200	New	+$24.3M	1.37%	21
2016 Q4	–	Sell	-203,400	Closed	-$19.6M	–	47
2016 Q3	$19.6M	Buy	+203,400	New	+$19.3M	1.73%	26

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Duquesne Family Office's IBB Position: Q2 2019 in Review

Duquesne Family Office sold out of iShares Biotechnology ETF (IBB) in Q2 2019, closing a stake of 791,200 shares — an estimated $88.5M sold.

Duquesne Family Office first reported a position in IBB in Q3 2016 and held it in 7 quarters. The position peaked at $126M in Q3 2018. 646 funds tracked by Wall St. Rank hold IBB as of Q2 2019.

Duquesne Family Office reported no remaining iShares Biotechnology ETF position as of Q2 2019 after selling out during the quarter.
Duquesne Family Office sold 791,200 iShares Biotechnology ETF shares in Q2 2019, an estimated $88.5M.
Duquesne Family Office first reported a position in iShares Biotechnology ETF in Q3 2016 and held it in 7 quarters.
Duquesne Family Office's iShares Biotechnology ETF position peaked at $126M in Q3 2018.
646 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2019.

Based on Duquesne Family Office's 13F filing for Q2 2019, filed 14 Aug 2019.